## Diagnosis of Graves' Disease ### Clinical Context The patient presents with classic features of hyperthyroidism (palpitations, tremor, heat intolerance) and a diffuse goiter with suppressed TSH. While TSH suppression confirms thyroid hormone excess, the **specific etiology** must be determined. ### Why TSH Receptor Antibodies (TRAb) Are Diagnostic **Key Point:** TSH receptor antibodies (TRAb) are **pathognomonic for Graves' disease** — they directly bind to and activate the TSH receptor, causing autonomous thyroid hormone production and thyroid growth. **High-Yield:** TRAb positivity definitively distinguishes Graves' disease from: - Thyroiditis (where TRAb is negative) - Toxic nodule/multinodular goiter (where TRAb is negative) - Iodine-induced hyperthyroidism (where TRAb is negative) ### Role of Radioiodine Uptake Scan The **radioiodine uptake (RAIU) scan** provides complementary functional information: - In Graves' disease: **diffuse, high uptake** (uniform distribution across the gland) - In thyroiditis: **low uptake** (destroyed follicles cannot trap iodine) - In toxic nodule: **focal high uptake** with suppressed uptake in remainder **Clinical Pearl:** TRAb + RAIU scan together provide both immunological confirmation and functional imaging, making this the gold standard diagnostic approach. ### Comparison of Investigations | Investigation | Graves' Disease | Thyroiditis | Toxic Nodule | |---|---|---|---| | **TSH** | Suppressed | Suppressed | Suppressed | | **Free T4/T3** | Elevated | Elevated | Elevated | | **TRAb** | **Positive** | Negative | Negative | | **TPO/Tg Ab** | May be present | Often present | Negative | | **RAIU** | Diffuse, high | Low | Focal, high | **Mnemonic:** **TRAB-RAIU** = The definitive duo for Graves' — **TRA**b confirms immunology, **RAIU** confirms diffuse uptake pattern.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.